Matches in SemOpenAlex for { <https://semopenalex.org/work/W2969324208> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W2969324208 endingPage "1561" @default.
- W2969324208 startingPage "1555" @default.
- W2969324208 abstract "There is a clear unmet need in people living with type 1 diabetes (T1D). Although the quality of life of people with T1D has improved, issues like hypoglycemia, weight gain and variability in glucose profiles remain. In this review, the clinical efficacy and safety of empagliflozin, a sodium-glucose cotransporter type 2 (SGLT2) inhibitor in T1D, is described based on a review of phase 2 and 3 studies to date. Empagliflozin and SGLT2 inhibitors, in general, are effective glucose-lowering drugs, which also work in people with T1D. Recent phase II and III studies, including the EASE trials for empagliflozin, showed a clear beneficial effect on HbA1c, body weight, glucose variability and total daily insulin use in people with T1D. No increase in hypoglycemia risk, in particular severe hypoglycemia, was observed, but genital infections were more prevalent. The use of SGLT2 inhibitors comes with a decrease in insulin doses, making individuals more prone to diabetic ketoacidosis (DKA). The uniqueness of the EASE program is that here, a very low dose of empagliflozin was used, with less, but still present, effects on metabolic outcomes, but interestingly a lower risk of DKA. Importantly, even in the higher doses of empagliflozin, it is clear that the overall risk for DKA remains low, most likely by educating patients and caretakers intensively on this subject. In conclusion, evidence is building on the potential of using empagliflozin, like other SGLT2 inhibitors, in T1D. However, to date, the use of empagliflozin is not approved in people with T1D. Clinicians will have to weigh the potential short- and long-term benefits of these adjunct therapies versus the potential acute side effects, in particular, the small but real risk of DKA in the individual T1D patient." @default.
- W2969324208 created "2019-08-29" @default.
- W2969324208 creator A5033414318 @default.
- W2969324208 creator A5051678362 @default.
- W2969324208 creator A5053469409 @default.
- W2969324208 date "2019-08-01" @default.
- W2969324208 modified "2023-10-15" @default.
- W2969324208 title "<p>Empagliflozin in type 1 diabetes</p>" @default.
- W2969324208 cites W1943654307 @default.
- W2969324208 cites W2044904729 @default.
- W2969324208 cites W2099670937 @default.
- W2969324208 cites W2146264128 @default.
- W2969324208 cites W2146681227 @default.
- W2969324208 cites W2188909866 @default.
- W2969324208 cites W2307842626 @default.
- W2969324208 cites W2425017047 @default.
- W2969324208 cites W2494601841 @default.
- W2969324208 cites W2514658869 @default.
- W2969324208 cites W2567623101 @default.
- W2969324208 cites W2584637681 @default.
- W2969324208 cites W2591693397 @default.
- W2969324208 cites W2626446274 @default.
- W2969324208 cites W2755899227 @default.
- W2969324208 cites W2756104796 @default.
- W2969324208 cites W2809153459 @default.
- W2969324208 cites W2809590939 @default.
- W2969324208 cites W2884380775 @default.
- W2969324208 cites W2894624538 @default.
- W2969324208 cites W2894993577 @default.
- W2969324208 cites W2896925990 @default.
- W2969324208 cites W2898388822 @default.
- W2969324208 cites W2900413769 @default.
- W2969324208 cites W2913123058 @default.
- W2969324208 doi "https://doi.org/10.2147/dmso.s194688" @default.
- W2969324208 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6709813" @default.
- W2969324208 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31686876" @default.
- W2969324208 hasPublicationYear "2019" @default.
- W2969324208 type Work @default.
- W2969324208 sameAs 2969324208 @default.
- W2969324208 citedByCount "7" @default.
- W2969324208 countsByYear W29693242082020 @default.
- W2969324208 countsByYear W29693242082021 @default.
- W2969324208 countsByYear W29693242082022 @default.
- W2969324208 crossrefType "journal-article" @default.
- W2969324208 hasAuthorship W2969324208A5033414318 @default.
- W2969324208 hasAuthorship W2969324208A5051678362 @default.
- W2969324208 hasAuthorship W2969324208A5053469409 @default.
- W2969324208 hasBestOaLocation W29693242081 @default.
- W2969324208 hasConcept C126322002 @default.
- W2969324208 hasConcept C134018914 @default.
- W2969324208 hasConcept C2775887513 @default.
- W2969324208 hasConcept C2777180221 @default.
- W2969324208 hasConcept C2779306644 @default.
- W2969324208 hasConcept C2780668416 @default.
- W2969324208 hasConcept C2781232474 @default.
- W2969324208 hasConcept C2781283889 @default.
- W2969324208 hasConcept C555293320 @default.
- W2969324208 hasConcept C71924100 @default.
- W2969324208 hasConceptScore W2969324208C126322002 @default.
- W2969324208 hasConceptScore W2969324208C134018914 @default.
- W2969324208 hasConceptScore W2969324208C2775887513 @default.
- W2969324208 hasConceptScore W2969324208C2777180221 @default.
- W2969324208 hasConceptScore W2969324208C2779306644 @default.
- W2969324208 hasConceptScore W2969324208C2780668416 @default.
- W2969324208 hasConceptScore W2969324208C2781232474 @default.
- W2969324208 hasConceptScore W2969324208C2781283889 @default.
- W2969324208 hasConceptScore W2969324208C555293320 @default.
- W2969324208 hasConceptScore W2969324208C71924100 @default.
- W2969324208 hasLocation W29693242081 @default.
- W2969324208 hasLocation W29693242082 @default.
- W2969324208 hasLocation W29693242083 @default.
- W2969324208 hasLocation W29693242084 @default.
- W2969324208 hasLocation W29693242085 @default.
- W2969324208 hasOpenAccess W2969324208 @default.
- W2969324208 hasPrimaryLocation W29693242081 @default.
- W2969324208 hasRelatedWork W1983641721 @default.
- W2969324208 hasRelatedWork W1995945960 @default.
- W2969324208 hasRelatedWork W2026226896 @default.
- W2969324208 hasRelatedWork W2066345847 @default.
- W2969324208 hasRelatedWork W2076974163 @default.
- W2969324208 hasRelatedWork W2089387278 @default.
- W2969324208 hasRelatedWork W2092579885 @default.
- W2969324208 hasRelatedWork W2095179743 @default.
- W2969324208 hasRelatedWork W2121663374 @default.
- W2969324208 hasRelatedWork W3152935002 @default.
- W2969324208 hasVolume "Volume 12" @default.
- W2969324208 isParatext "false" @default.
- W2969324208 isRetracted "false" @default.
- W2969324208 magId "2969324208" @default.
- W2969324208 workType "article" @default.